Hong Kong’s cumulative coronavirus infections have exceeded one million as the city grapples with a widespread outbreak that has killed more people than the reported COVID-19 deaths in all of mainland China.
Health officials reported 20,079 confirmed infections on Friday, taking the total since the start of the pandemic to 1,016,944.
Nearly 97 percent of those came from Hong Kong’s current wave, which began in December. Since February 9, nearly 5,200 people have died from the virus.
For more coronavirus news, visit our dedicated page.
The total number of deaths in Hong Kong, 5,401, have exceeded the fatalities recorded in mainland China at 4,636. Mainland authorities have counted 126,234 confirmed cases, but unlike most countries, China does not include asymptomatic cases in its confirmed total.
The city of 7.4 million is in the grip of an omicron surge that has strained its health care system as hospitals reached maximum capacity. Coffins are running out and mortuaries are so full that bodies have to be temporarily stored in refrigerated containers.
Most of the deceased were elderly patients, a majority of whom are not fully vaccinated.
For most of the pandemic, Hong Kong was able to stamp out earlier outbreaks with tough “zero COVID-19” restrictions that temporarily shuttered businesses, limited public gatherings and imposed entry curbs such as lengthy quarantines for arrivals and flight bans from countries deemed high-risk.
That changed with the highly transmissible omicron variant. Officials have sought assistance from mainland China, which has sent experts and medical resources to help Hong Kong combat the pandemic.
Fauci warns of potential rise in US COVID-19 cases as funding runs dryThe US could soon see COVID-19 cases rise again and vulnerable people are likely to need a fourth vaccine dose, one of President Joe Biden’s top ... Coronavirus
EMA expects data on omicron-specific vaccine as early as AprilThe European Medicines Agency’s (EMA) leading vaccine expert on Thursday said that data on COVID-19 vaccines tailored for the omicron variant should ... Coronavirus
AstraZeneca COVID-19 antibody therapy for poor immunity gets UK approvalAn antibody therapy developed by AstraZeneca Plc won regulatory clearance in the UK to prevent COVID-19 in patients with poor immune defenses. For the ... Coronavirus